Toronto Dominion Bank increased its stake in shares of Henry Schein, Inc. (NASDAQ:HSIC) by 124.0% in the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 60,185 shares of the company’s stock after purchasing an additional 33,313 shares during the quarter. Toronto Dominion Bank’s holdings in Henry Schein were worth $4,934,000 as of its most recent filing with the SEC.
Several other hedge funds also recently bought and sold shares of HSIC. YorkBridge Wealth Partners LLC boosted its holdings in shares of Henry Schein by 5.2% during the second quarter. YorkBridge Wealth Partners LLC now owns 570 shares of the company’s stock worth $104,000 after purchasing an additional 28 shares during the period. Sun Life Financial INC boosted its holdings in shares of Henry Schein by 8,185.7% during the second quarter. Sun Life Financial INC now owns 580 shares of the company’s stock worth $106,000 after purchasing an additional 573 shares during the period. Trust Co. of Vermont boosted its holdings in shares of Henry Schein by 56.7% during the third quarter. Trust Co. of Vermont now owns 1,702 shares of the company’s stock worth $140,000 after purchasing an additional 616 shares during the period. Lee Financial Co acquired a new stake in shares of Henry Schein during the second quarter worth approximately $161,000. Finally, Benjamin F. Edwards & Company Inc. boosted its holdings in shares of Henry Schein by 281.8% during the third quarter. Benjamin F. Edwards & Company Inc. now owns 2,100 shares of the company’s stock worth $172,000 after purchasing an additional 1,550 shares during the period. Institutional investors and hedge funds own 53.07% of the company’s stock.
Several equities analysts recently weighed in on the stock. Piper Jaffray Companies raised shares of Henry Schein from a “neutral” rating to an “overweight” rating in a research report on Friday, September 15th. Royal Bank Of Canada assumed coverage on shares of Henry Schein in a research report on Tuesday, September 19th. They set a “sector perform” rating and a $91.00 price objective on the stock. Zacks Investment Research lowered shares of Henry Schein from a “buy” rating to a “hold” rating in a research report on Wednesday, August 9th. Jefferies Group LLC cut their price objective on shares of Henry Schein from $89.00 to $74.00 and set a “hold” rating on the stock in a research report on Tuesday, November 7th. Finally, TheStreet lowered shares of Henry Schein from a “b” rating to a “c+” rating in a research report on Monday, November 6th. Two analysts have rated the stock with a sell rating, eight have given a hold rating and seven have given a buy rating to the stock. The stock has an average rating of “Hold” and a consensus price target of $89.88.
Henry Schein, Inc. (NASDAQ HSIC) opened at $69.12 on Friday. Henry Schein, Inc. has a 52-week low of $65.28 and a 52-week high of $93.50. The company has a market cap of $10,848.66, a P/E ratio of 19.39, a PEG ratio of 1.95 and a beta of 1.03. The company has a debt-to-equity ratio of 0.30, a current ratio of 1.55 and a quick ratio of 0.86.
Henry Schein (NASDAQ:HSIC) last released its quarterly earnings results on Monday, November 6th. The company reported $0.87 EPS for the quarter, missing the Zacks’ consensus estimate of $0.90 by ($0.03). Henry Schein had a net margin of 4.52% and a return on equity of 19.71%. The firm had revenue of $3.16 billion during the quarter, compared to the consensus estimate of $3.05 billion. During the same period in the prior year, the business earned $0.84 EPS. The company’s revenue for the quarter was up 10.3% compared to the same quarter last year. sell-side analysts forecast that Henry Schein, Inc. will post 3.6 EPS for the current year.
Henry Schein declared that its Board of Directors has initiated a share buyback program on Monday, September 18th that authorizes the company to buyback $400.00 million in outstanding shares. This buyback authorization authorizes the company to buy up to 6.3% of its shares through open market purchases. Shares buyback programs are typically a sign that the company’s management believes its stock is undervalued.
In other news, SVP Paul Rose sold 2,126 shares of Henry Schein stock in a transaction that occurred on Wednesday, September 6th. The shares were sold at an average price of $172.51, for a total value of $366,756.26. Following the transaction, the senior vice president now owns 17,841 shares of the company’s stock, valued at $3,077,750.91. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. Company insiders own 1.19% of the company’s stock.
Henry Schein Company Profile
Henry Schein, Inc is a provider of healthcare products and services primarily to office-based dental, animal health and medical practitioners. The Company operates through two segments: healthcare distribution, and technology and value-added services. The healthcare distribution segment distributes consumable products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products and vitamins.
Want to see what other hedge funds are holding HSIC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Henry Schein, Inc. (NASDAQ:HSIC).
Receive News & Ratings for Henry Schein Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein Inc. and related companies with MarketBeat.com's FREE daily email newsletter.